Publication Name	世界华人消化杂志
手稿编号	39427
手稿来源省、自治区或特别行政区	浙江省

Received	2023-03-25 07:48
Peer-Review Started	2023-03-25 12:38
To Make the First Decision
Return for Revision	2023-04-19 23:05
修回稿	2023-04-24 08:09
Second Decision	2023-05-18 12:22
期刊总编辑接受
公司总编辑接受	2023-05-18 23:03
预出版	2023-05-18 23:03
缴纳版面费
Edit the Manuscript by Language Editor
排版	2023-05-26 06:54
在线出版	2023-05-26 12:36

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化肿瘤学
手稿栏目类型	文献综述
文章标题	生物标志物在肝细胞癌诊断与治疗中的研究进展
手稿来源	自由来稿
所有作者列表	徐飞麒, 张哲, 胡昂, 黄东胜
基金项目及其编号
通讯作者	黄东胜, 博士, 教授, 314408, 杭州市拱墅区上塘路158号, 浙江省人民医院肝胆胰微创外科. Huangdongshengsj@hotmail.com
关键词	肝细胞癌; 生物标志物; 诊断; 预后; 液体活检
核心内容提要	肝细胞癌(hepatocellular carcinoma, HCC)早期诊断困难, 治疗后复发率高, 患者预后较差. 近年来随着各种新型生物标志物的出现, 基于生物标志物构建的数理统计模型的运用, 以及液体活检技术的发展, HCC患者的诊疗现状得到了极大改善.
出版日期	2023-05-26 12:36
引文著录	徐飞麒, 张哲, 胡昂, 黄东胜. 生物标志物在肝细胞癌诊断与治疗中的研究进展. 世界华人消化杂志 2023; 31(10): 404-411
URL	https://www.wjgnet.com/1009-3079/full/v31/i10/404.htm
DOI	https://dx.doi.org/10.11569/wcjd.v31.i10.404

Full Article (PDF)	WCJD-31-404.pdf
审稿意见	WCJD-39427-Peer-review(s).pdf
科学编辑工作清单	WCJD-39427-Scientific editor work list.pdf